Implant Veterans of Toxic Exposure

Hancock
Home
Action
Alerts
Hayes
Congressional Report
AMT-1
AMT Audit
Fly-In
ASPRS Survey
Bell & Pointer
BI Capsules
BI Chemicals
BI Numbers - Dow
Burson-Marsteller
B-M's Spokesdoctors
Dr. Pierre Blais
Burson - NEW
Cab-O-Sil
CANDO
Capsules
Chemical Adverse
ChemBMS
Children
Chem Soup
Connie Chung
CRS_safety
Dowknew1
Dowknew2
Dowknew3
Dowknew4
Dow Bleed
Dow Disease
Dow Fraud
Dow Migration
Dow Rupture
DC Whines
Dr. Anderson
Explant
Gagged
Gel Reaction
Griffin Bell
Hancock
Harvard-Brigham
HAD
Inflammation
Jenny
Judge Jones Transcript
Kessler
Latissimus
Maryland Informed
McKennon
McGhan-Shells
Poem to Congress
No Evidence
Cole
Norman Cole
Notable People
Scleroderma
SS
Study-Adjuvant
Study-Adjuvant-FDA
Study-Beagle
Study-Dogs
Study NY
Study-Tissue Reaction
Talcott
Testimony
Ultra Sound
Links

AFFIDAVIT OF WAYNE M. HANCOCK:
On February 18, 1992, Wayne M. Hancock, who has been an attorney for Dow Chemical since 1967 signed the following affidavit:

AFFIDAVIT OF WAYNE M. HANCOCK:
Date: Tue, 12 Oct 1999 18:36:59 -0600
AFFIDAVIT OF WAYNE M. HANCOCK:
On February 18, 1992, Wayne M. Hancock, who has been an attorney for Dow Chemical since 1967 signed the following affidavit:


AFFIDAVIT
STATE OF MICHIGAN:
COUNTY OF MIDLAND:
I, Wayne M. Hancock, being duly sworn, deposes and says:
(1). That I am General Counsel for the Dow Chemical Company. I have held that position since October 1, 1981. I have been an attorney for The Dow Chemical Company since 1967. In addition, I have been a Dow Chemical Company Vice President since January 17, 1985.
(2). That I am familiar with all facets of The Dow Chemical Company's business, that products manufacturered by The Dow Chemical Company and The Dow Chemical Company's relationship to Dow Corning Corporation.
(3). That prior to December 3, 1991, Dow Corning Corporation's stock was fifty (50%) percent owned by Corning, Inc., and fifty (50%) percent owned byThe Dow Chemical Company.
(4). That on December 3, 1991, The Dow Chemical Company transferred all of its interest in Dow Corning Corporation to Dow Holdings, Inc., an indirect, wholly owned subsidiary of The Dow Chemical Company.
(5). That Dow Holdings, Inc., is owned 100% by Dow Financial Holdings, Inc., a wholly owned subsidiary of The Dow Chemical Company.
(6). That The Dow Chemical Company is a manufacturer of chemicals and chemical compounds.
(7). That Corning Incorporation is a manufacturers of specialty glass products.
(8). That Dow Corning Corporation is a manufacturer of silicone products, including silicone mammary implants.
(9). That Dow Corning Corporation is an independent company and solely responsible for the manufacture of its silicone implants.
(10). That The Dow Chemical Company (including its divisions and subsidiaries) is not and never has been in the business of manufacturing, designing, testing, distributing, selling and/or promoting silicone mammary implants, or any product similar to such product in design, manufacturer or use.
(11). That Dow Corning Corporation is not an instrumentality of the Dow Chemical Company. Although, prior to December 3, 1991, The Dow Chemical Company owned fifty percent (50%) of the common stock of Dow Corning corporation, and that stock is currently owned by an indirect subsidiary of The Dow Chemical Company. The Dow Chemical Company (including its divisions and subsidiaries) maintains separate and independent places of business, offices, employees, corporate books, records and management operations from those of Dow Corning Corporation; and the only interest of The Dow Chemical Company (including its divisions and subsidiaries) in Dow Corning Corporation was or is as a shareholder thereof.
(12). That the Dow Chemical Company (including any of its divisions or subsidiaries) does not currently and never has manufacturered any silicone medical devices or mammary prosthetic devices of any type. specifically, the Dow Chemical Company does not produce, manufacture, distribute or market silicone mammary implants or "any component," raw material or "intermediate" thereof.


(13). That the Dow Chemical Company (including any of its divisions or subsidiaries) has never been involved in any research, testing, design or development of any Dow Corning Corporation silicone mammary implants, or silicone mammary implants manufactured by any other entity or manufacturer. Also, the Dow Chemical Company has never been involved in any research, testing, design or development concerning the applicability or suitability of any components, raw materials or intermediates for use in silicone mammary implants.
(14). That the Dow Chemical Company (including any of its divisions or subsidiaries) has conducted a limited amount of testing which primarily involves industrial and commercial silicone products or products with silicone components. The Dow Chemical Company has never been requested by Dow Corning Corporation or any other entity to test, research or evaluate the safety of any silicone mammary implants or the safety or suitability of any silicone materials for use as components. The Dow Chemical Company has never been requested by Dow Corning Corporation or any other entity to test, research or evaluate the safety of any silicone mammary implants or the safety or suitability of any silicone materials for use as components or intermediates of silicone mammary implants.
(15). That the Dow Chemical Company (including any of its divisions or subsidiaries) has never exercised any control or direction over Dow Corning corporation relative to the design, testing, manufacturer, sale, distribution or promotion of Dow Corning corporation silicone mammary implants, nor any component, raw material or intermediate thereof.
(16). That the Dow Chemical Company (including any of its division or subsidiaries) does not possess, maintain or control any documents or other physical evidence relating to the design, testing, manufacture, sale, distribution or promotion of Dow Corning Corporation silicone mammary implants.
(17). That the Dow Chemical Company has no information or knowledge that any chemicals or compounds manufactured by the Dow Chemical Company are contained in silicone mammary products manufactured by Dow Corning Corporation.
FURTHER AFFIANT SAYETH NAUGHT.
Signed by: Wane M. Hancock
The foregoing was subscribed and sworn to before me by Wayne M. Hancock this 18th day of February, 1992. Cheryl A. Johnson, Notary Public. My Commission Expires: April 22, 1995

Note: This financial transfer into Dow Holding, Inc., was timed before the moratoriam on silicone implants took place in 1992. The Dow Chemical Company owns insurance company subsidiaries, and also owns its DOWRINCO (Dow Reinsurance Company) subsidiary company. Reinsurance company conglomerates in turn insure smaller insurance companies against their catastrophic claims. Through their corporate insurance and banking ties, (the Mellon Family's: General Re Reinsurance, and General Electric's: Employers Insurance Co., they can possibily mastermind the small insurance companies NOT to pay out on their breast implant claims. The Dow Chemical Company is, along with Corning Glass, the sole beneficiary of the Dow Corning insurance claims. Dow Corning was 100% self-insured through its parent companies.
Ken Ferraro, a company spokesperson for ITT Hartford Insurance Group of Hartford, Connecticut said that his company insured Dow Corning from 1972 through 1989. The coverage has been "on top of" Dow's self-insurance layer for some of that time. Dow Corning is 100% SELF-INSURED for the first $3 Million PER OCCURRENCE OF PRODUCT LIABILITY COVERAGE. Seventy-three insurance companies provided Dow Corning with $3.48 Billion worth of EXCESS LIABILITY COVERAGE dating back to 1962. These 73 insurance companies had REINSURANCE COMPANIES (Lloyds of London, etc.) reinsuring them for their loss. Lloyds of London has a strict policy of constantly reviewing their coverage and the insurance companies under them.

Site maintained by Pamela G. Dowd